Healthpeak Properties

Healthpeak PropertiesHealthpeak Properties
Healthpeak Properties

Healthpeak Properties

A leading owner, operator, and developer of real estate for healthcare discovery and delivery.

DR 521985Active300Denver, United States
Rate

About

Healthpeak Properties, Inc. is a real estate investment trust (REIT) that focuses on owning, operating, and developing properties for the healthcare industry. Their portfolio includes life science, medical office, and senior housing facilities, catering to the needs of healthcare discovery and delivery.
Frequently asked

What does Healthpeak Properties do?

Healthpeak Properties, Inc. is a real estate investment trust (REIT) that focuses on owning, operating, and developing properties for the healthcare industry. Their portfolio includes life science, medical office, and senior housing facilities, catering to the needs of healthcare discovery and delivery.

What is Healthpeak Properties's revenue?

StartupHub estimates Healthpeak Properties's annual revenue at $50.4M (range $30.1M to $79.0M, 67% confidence), based on comparable companies in the sector.

What is Healthpeak Properties's valuation?

StartupHub estimates Healthpeak Properties's effective valuation at $33.0B (range $29.2B to $81.1B, 46% confidence), based on comparable companies in the sector.

How much funding has Healthpeak Properties raised?

Healthpeak Properties has raised a total of $20.0B in funding. The most recent round on record is Public.

Where is Healthpeak Properties headquartered?

Healthpeak Properties is headquartered in Denver, Colorado, United States.

When was Healthpeak Properties founded?

Healthpeak Properties was founded in 1985.

What industry does Healthpeak Properties operate in?

Healthpeak Properties operates in Healthcare, Real Estate, Life Sciences, Medical Office Buildings, Senior Housing, Real Estate Investment Trust.

How many employees does Healthpeak Properties have?

Healthpeak Properties has approximately 300 people on record.

HEADCOUNT
300
DOMAIN RATING
52
Comments

No comments yet. Be the first to share your take.